Patents by Inventor Atsuhito Yoshida

Atsuhito Yoshida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolo[1,2-]pyridazine derivatives
    Patent number: 7300932
    Abstract: Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the activity of proteins involved in lipid metabolism and cell proliferation.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: November 27, 2007
    Assignee: Japan Tobacco Inc.
    Inventors: Brian M. Fox, Kiyosei Iio, Takashi Inaba, Frank Kayser, Kexue Li, Shoichi Sagawa, Masahiro Tanaka, Atsuhito Yoshida
  • Fused-ring compounds and use thereof as drugs
    Patent number: 7285551
    Abstract: The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.
    Type: Grant
    Filed: July 8, 2003
    Date of Patent: October 23, 2007
    Assignee: Japan Tobacco Inc.
    Inventors: Hiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida
  • Fused Bicyclic Nitrogen-Containing Heterocycles
    Publication number: 20070244096
    Abstract: Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the activity of proteins involved in lipid metabolism and cell proliferation.
    Type: Application
    Filed: May 2, 2007
    Publication date: October 18, 2007
    Applicant: Japan Tobacco Inc.
    Inventors: Brian Fox, Noboru Furukawa, Xiaolin Hao, Kiyosei Iio, Takashi Inaba, Simon Jackson, Frank Kayser, Marc Labelle, Kexue Li, Takuya Matsui, Dustin McMinn, Nobuya Ogawa, Steven Rubenstein, Shoichi Sagawa, Kazuyuki Sugimoto, Masahiro Suzuki, Masahiro Tanaka, Guosen Ye, Atsuhito Yoshida, Jian Zhang
  • Fused bicyclic nitrogen-containing heterocycles
    Patent number: 7244727
    Abstract: Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the activity of proteins involved in lipid metabolism and cell proliferation.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: July 17, 2007
    Assignee: Japan Tobacco Inc.
    Inventors: Brian M. Fox, Noboru Furukawa, Xiaolin Hao, Kiyosei Iio, Takashi Inaba, Simon M. Jackson, Frank Kayser, Marc Labelle, Kexue Li, Takuya Matsui, Dustin L. McMinn, Nobuya Ogawa, Steven M. Rubenstein, Shoichi Sagawa, Kazuyuki Sugimoto, Masahiro Suzuki, Masahiro Tanaka, Guosen Ye, Atsuhito Yoshida, Jian Zhang
  • Fused-ring compounds and use thereof as drugs
    Publication number: 20070032497
    Abstract: The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hapatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.
    Type: Application
    Filed: March 28, 2005
    Publication date: February 8, 2007
    Applicant: Japan Tobacco Inc.
    Inventors: Hiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida
  • Fused-ring compounds and use thereof as drugs
    Patent number: 7112600
    Abstract: The present invention provides a fused ring compound of the following formula [I] ? wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: September 26, 2006
    Assignee: Japan Tobacco Inc.
    Inventors: Hiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida
  • Pyrrolo[1,2-b]pyridazine derivatives
    Publication number: 20050070545
    Abstract: Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the activity of proteins involved in lipid metabolism and cell proliferation.
    Type: Application
    Filed: August 6, 2004
    Publication date: March 31, 2005
    Applicants: Tularik Inc., Japan Tobacco, Inc.
    Inventors: Brian Fox, Kiyosei Iio, Takashi Inaba, Frank Kayser, Kexue Li, Shoichi Sagawa, Masahiro Tanaka, Atsuhito Yoshida
  • Fused bicyclic nitrogen-containing heterocycles
    Publication number: 20040209871
    Abstract: Compounds, pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the activity of proteins involved in lipid metabolism and cell proliferation.
    Type: Application
    Filed: November 21, 2003
    Publication date: October 21, 2004
    Applicants: Tularik Inc., Japan Tobacco Inc.
    Inventors: Brian M. Fox, Noboru Furukawa, Xiaolin Hao, Kiyosei Iio, Takashi Inaba, Simon M. Jackson, Frank Kayser, Marc Labelle, Kexue Li, Takuya Matsui, Dustin L. McMinn, Nobuya Ogawa, Steven M. Rubenstein, Shoichi Sagawa, Kazuyuki Sugimoto, Masahiro Suzuki, Masahiro Tanaka, Guosen Ye, Atsuhito Yoshida, Jian Zhang
  • Fused-ring compounds and use thereof as drugs
    Patent number: 6770666
    Abstract: The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound of the present invention shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: August 3, 2004
    Assignee: Japan Tobacco Inc.
    Inventors: Hiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida
  • Fused-ring compounds and use thereof as drugs
    Publication number: 20040097438
    Abstract: The present invention provides a fused ring compound of the following formula [I] 1
    Type: Application
    Filed: July 8, 2003
    Publication date: May 20, 2004
    Applicant: Japan Tobacco Inc.
    Inventors: Hiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida
  • Fused cyclic compounds and medicinal use thereof
    Publication number: 20040082635
    Abstract: The present invention provides a fused ring compound of the following formula [I] 1
    Type: Application
    Filed: February 18, 2003
    Publication date: April 29, 2004
    Inventors: Hiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida
  • Fused-ring compounds and use thereof as drugs
    Publication number: 20030050320
    Abstract: The present invention provides a fused ring compound of the following formula [I] 1
    Type: Application
    Filed: August 24, 2001
    Publication date: March 13, 2003
    Applicant: Japan Tobacco Inc.
    Inventors: Hiromasa Hashimoto, Kenji Mizutani, Atsuhito Yoshida